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Abstract Secretion of procathepsin L into the culture medium 
from a bone cell mixture was markedly enhanced by addition of 
parathyroid hormone (PTH), 1 a,25-(OH)2D 3or tumor necrosis 
factor a (TNFa). These stimulators of secretion of procathepsin 
L enhanced bone pit formation, which was inhibited by E-64, but 
not by CA-074, a specific inhibitor of cathepsin B. Procathepsin 
L may thus participate in the process of bone collagenolysis 
during bone resorption. Procathepsin L partially purified from rat 
long bones under cold conditions was rapidly converted to the 
mature form under acidic conditions at room temperature. This 
conversion was inhibited by E-64, suggesting that the procathep- 
sin L secreted into lacunae is catalytically converted to the ma- 
ture enzyme by cysteine proteinase(s). 
In the present study, designed to clarify the mechanism and 
regulation of both the secretion of procathepsin L and its proc- 
essing in lacunae, we examined the secretion of procathepsin 
L induced by 10~,25-(OH)2D 3, TNFc~ or by PTH, and also the 
effects of the cysteine proteinase inhibitors, E-64 and CA-074, 
on the pit formation induced by these effectors. Furthermore, 
to clarify the participation ofcysteine proteinase(s) in process- 
ing from the precursor to the active form, the inhibitory effect 
of E-64 on the processing of procathepsin L partially purified 
from rat long bones was also examined. 
2. Experimental 
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1. Introduction 
Osteoclasts are multinucleated cells mainly responsible for 
the degradation of both mineral and organic omponents dur- 
ing the process of bone resorption [1-3]. Activated osteaclasts 
excrete protons and lysosomal proteinases into the extracellular 
microenvironment called Howship's lacunae under their ruffled 
borders. These protons are thought o be involved in not only 
the degradation of bone mineral, chiefly solid calcium hydrox- 
yapatite, but also in activation of cysteine proteinases by acid- 
ification of the lacunae. The lysosomal proteinases secreted into 
the lacunae, possibly cysteine proteinases, have been thought 
to play an important role in osseous collagenolysis [1,3-8] 
We previously reported [9] that the bone pit formation stim- 
ulated by PTH was significantly suppressed by specific inhib- 
itors of cathepsin L and L-type proteinases, but not by those 
of cathepsins B and D. Moreover, we also demonstrated [10] 
that the increase in pit formation stimulated by PTH paralleled 
the increase of a 39 kDa precursor form of cathepsin L secreted 
into media, and that both increases induced by PTH were 
markedly inhibited by addition of calcitonin. These findings 
indicate that the secretion of procathepsin L from osteoclasts 
is an important process in PTH-induced bone resorption. 
2.1. Materials 
E-64-a and CA-074 were kindly supplied by Taisho Pharmaceutical 
Co. (Saitama, Japan). Rabbit anti-rat cathepsin L was donated by Dr. 
E. Kominami (Department of Biochemistry, Juntendo University, 
School of Medicine, Japan). Fetal bovine serum (FBS) was from Gibco 
(Grand Island, NY), lc~,25-(OH)zD 3 and TNF~ was purchased from 
FunakoshiCo. (Tokyo, Japan), and human PTH (1 34) from Peninsula 
Laboratories Inc. (Belmond, CA). All other chemicals were of analyti- 
cal grade. Sephadex G-75 and S-Sepharose were purchased from Phar- 
macia (Uppsala, Sweden). YM-10 membrane was purchased from 
Amicon (Japan). Male Spragu~Dawley (SD) rats (1-2 days and (~7 
weeks old) were purchased from Charles River, Japan. Low calcium 
diet (ca. 0.02 0.03%), a slight modified Diet-I 1, was purchased from 
Nippon Clea (Osaka, Japan). 
2.2. Assay of bone resorption 
Bone resorption was carried out according to the method of 
McSheehy and Chambers [11] with modifications a described previ- 
ously [9]. For Western blotting analysis, the media were collected at 72 
h after addition of bone resorption factor, concentrated 50times and 
subjected toSDS-PAGE. 
2.3. Electrophoresis and Western blotting analysis 
SDS-PAGE was performed by the method of Laemmli [12] in a 
15 25% gradient gel containing 0.1% SDS and 5% 2-mercaptoethanol 
at room temperature, and transferred electrophoretically to an Immo- 
bilon transfer membrane (Millipore). The SDS-PAGE low-range stand- 
ards (Bio-Rad, Richmond) used as molecular weight markers were 
BSA (80 kDa), ovalbumin (49.5 kDa), carbonic anhydrase (32.5 kDa), 
soybean trypsin inhibitor (27.5 kDa) and lysozyme (18.5 kDa). Im- 
munoblotting was developed using rabbit anti-rat cathepsin L as the 
first antibody, and bound antibodies were detected by goat anti-rabbit 
IgG-conjugated alkaline phosphatase. The alkaline phosphatase r ac- 
tion was performed using Picoblue Immunoscreening Kits (Stratagene, 
CA). 
*Corresponding author. Fax: (81) (886) 22-3217. 
Abbreviations." Z, benzyloxycarbonyl; MCA, methylcoumaryl-amide; 
E-64-a, N-(L-3-trans-carboxyoxirane-2-carbonyl-L-leucine-4-aminobu- 
tylamide; CA-074, N-(L-3-trans-propylcarbamoyloxirane-2-carbonyl)- 
L-isoleucyl-L-proline. Enzyme." cathepsin L, EC 3.4.22.15. 
2.4. Enzyme preparation 
The long bones, excised from male SD rats receiving a low calcium 
diet for one week, were homogenized and sonicated. The homogenate 
was centrifuged for 10 min at 12,000 rpm, and the supernatant then 
treated with (NH4)2SO 4.The material precipitated with 20-70% satu- 
ration was resuspended in 50 mM sodium acetate buffer, pH 5.5. Insol- 
uble materials were removed by centrifugation. The suspension was 
applied to a column of Sephadex G-75 equilibrated with the same 
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Fig. 1. (a) Time-dependent secretion of procathepsin L by PTH from 
bone cell mixture. (Lane A) Rat liver cathepsin L (b) Increase in secre- 
tion of procathepsin L by la,25-(OH)2D3 and TNFa. Lane A = Un- 
treated-group; lane B = la,25-(OH)2D3-plus-group; lane C = TNFa- 
plus-group. The culture media were concentrated 50 times, and were 
subjected to SDS-PAGE in the presence of 5% 2-mercaptoethanol. 
Western blotting analysis using rabbit anti-rat cathepsin L IgG was 
carried out as described in section 2. 
buffer. The enzyme fractions having the activity of cathepsin L were 
collected and concentrated by ultrafiltration on an Amicon YM-10 
membrane (Amicon, Japan). The Sephadex G-75 fraction was applied 
to a column of S-Sepharose. The column was washed with two bed 
volumes of the same buffers, and then developed with a linear gradient 
of 0.14).7 M NaC1 (total volume; 360 ml). The fractions having cathep- 
sin L activity were combined and concentrated. 
2.5. Effect of E-64 on the processing of procathepsin L 
The enzyme preparation was carried out as described above in the 
presence of 10 5 M E-64. The S-Sepharose fraction concentrated 100 
times in the absence or presence of E-64 was incubated for 30 min at 
37°C in 50 mM sodium acetate buffer, pH 4.5, subjected to SDS- 
PAGE, and transferred toa transfer membrane. Western blotting anal- 
ysis using rabbit anti-rat cathepsin L was performed as described above. 
2.6. Enzyme assay 
Cathepsin L activities were measured with Z-Phe-Arg-MCA as sub- 
strate at pH 5.5 [13]. The enzyme fraction was preincubated with 10 7 
M of CA-074 for 5 min at 37°C in 0.1 M sodium acetate buffer, pH 
79 
5.5, containing 8 mM cysteine and 1 mM EDTA. The mixture was then 
incubated with 2 × 10 5 M substrate for 10 min at 37°C. The fluores- 
cence of 7-amino-4-methylcoumaryl-amine liberated from the substrate 
was monitored by a fluorescence spectrometer (Hitachi F-2000). The 
Z-Phe-Arg-MCA hydrolizing activity in the presence of E-64 sub- 
tracted from that in the presence of CA-074 corresponds tothe activity 
of cathepsin L and L-type proteinase. 
3. Results and discussion 
3.1. Enhancement ofprocathepsin L secretion by bone resorption 
fclclors 
We previously reported [10] that a 39 kDa cysteine proteinase 
which seems to be a precursor form of mature cathepsin L (30 
kDa), was secreted into culture media of bone cell mixture at 
30 h after addit ion of PTH, during the process of pit formation. 
The amount  of procathepsin L secreted was increased by addi- 
tion of PTH, and this increase was markedly suppressed by 
calcitonin. Fig. la shows the time-dependency of the secretion 
of 39 kDa procathepsin L into the culture medium and the 
enhancement of its secretion by PTH. The effects of la,25- 
(OH)2D3 and TNFa  on the secretion of procathepsin L were also 
examined by Western blotting. The secretion of the proteinase 
into the culture medium was enhanced by addition of these 
bone resorption stimulators (Fig. lb). These findings indicate 
that the secretory cysteine proteinase is procathepsin L, which 
is secreted from osteoclasts indirectly activated by PTH, la,25- 
(OH)2D3 and TNFa  via osteoblastic functions. 
We also examined the effects of E-64 and CA-074 on pit 
formation induced by la,25-(OH)2D3, TNFa  and PTH. The 
areas of resorptive pits were markedly enhanced by addition 
of these enhancers of procathepsin L excretion. E-64 inhibited 
the pit formation enhanced by these factors in a dose-depend- 
ent manner at concentrations ranging from 10 7 to 10 4 M. On the 
Table 1 
Effects of E-64-a and CA-074 on the pit formation induced 
(OH)2D3, TNFa or PTH 
by la,25- 
Stimulator Inhibitor Concentration Relative pit for- 
(M) marion (%) 
lc~,25-(OH)2D 3 Blank* - 14.3 + 1.7"* 
Control - 100.0 + 8.3 
+E-64-a 10 7 71.8 + 7.2* 
10 6 38.5 + 3.5** 
+CA-074 10 7 106.5 + 12.1 
10 6 121.3 + 7.7 
TNF~ 
PTH 
Blank * 21.4 + 2.5** 
Control - 100.0 + 10.4 
+E-64-a 10 7 71.0 + 12.2 
10 6 19.1 _+ 5.2** 
+CA-074 10 7 105.9 + 9.0 
104 88.3 _+ 6.8 
Blank* 10.8 + 2.7** 
Control - 100.0 + 4.1 
+E-64-a 10 7 61.6 + 9.1"* 
10 6 48.6 + 4.9** 
+CA-074 10 7 94.2 + 26.9 
10 6 73.1 _+ 29.7 
*Spontaneous bone resorption. Concentrations of la,25-(OH)zD3, 
TNF~ and PTH were 10 s M. Each value indicates the mean + S.E.M. 
of 5-6 observations. 
**P < 0.01, *P < 0.05; significant difference from control group (Stu- 
dent's t-test). 
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Fig. 2. (a) Chromatographic profile on a S-Sepharose column. A 45.0 mg sample of the Sephadex G-75 fraction was applied to a column (1.8 x 18 
cm) of S-Sepharose equilibrated with 50 mM sodium acetate buffer, pH 5.5 The sample was eluted with a linear gradient of 0.14).7 M NaCI. (e) 
Cathepsin L activity (Z-Phe-Arg-MCA hydrolytic activity): (o) absorbance at280 nm; (---) concentration ofNaCl. (b) Western blotting analysis using 
rabbit anti-rat eathepsin L IgG on S-Sepharose fraction having cathepsin L activity. (Lane A) rat liver cathepsin L. (Lane B) S-Sepharose fraction 
'a' (before concentration). (Lane C) S-Sepharose (after concentration at pH 5.5). (Lane D) S-Sepharose fraction 'b'. 
other hand, no inhibition was observed with CA-074, a specific 
inhibitor of cathepsin B, in all of these cases. We previously 
reported that the bone resorption induced by PTH was mark- 
edly inhibited by pig leucocyte cysteine proteinase inhibitor 
(PLCPI), a specific inhibitor of cathepsin L, and by chy- 
mostatin, a selective inhibitor of cathepsin L, but not by CA- 
074. These findings indicate that cathepsin L and/or L-type 
cysteine proteinase, but not cathepsin B, is the main proteinase 
responsible for the PTH, l~,25-(OH)2D 3 and TNFct-induced 
bone collagenolysis. The present findings support he view that 
the bone collagenolysis nduced by various bone resorption 
stimulators, uch as 1c~,25-(OH)2D3, TNF~ and PTH, is mainly 
caused by stimulation of procathepsin L secretion. 
3.2. Participation of cysteine proteinase(s) in post-secretional 
processing of bone procathepsin L 
Cathepsin L is synthesized as a preproenzyme, which is 
cotranslationally processed to a proenzyme and then located to 
the Golgi apparatus. Procathepsin L is targeted to the lysosome 
mediated by mannose-6-phosphate s the sorting signal [14]. 
During the process of targetting of procathepsin L to the ly- 
sosome in the case of hepatocytes and fibroblasts, the pro- 







Fig. 3. Inhibitory effect of E-64 on the processing of procathepsin L.
Procathepsin L was processed in 0.1 M sodium acetate buffer, pH 4.5, 
for 30 rain in the presence (lane A) or absence (lane B) of 10 5 M E-64. 
Western blotting analysis was performed as described in section 2. 
cathepsin L is converted to the mature enzyme by processing 
proteinase(s) located in the lysosomal membrane. On the other 
hand, some cells have been recently shown to secrete pro- 
cathepsin L under regulation by physiological stimulators. For 
instance, the secretory protein appeared in the endometrium of
estrogen-primed cats after progesterone administration, and 
cyclic protein-2 secreted by mature rat Sertoli cells has been 
reported to be a precursor form of cathepsin L [15,16]. The 
secretory proteins are generally transferred to secretion gran- 
ules from the ER via the trans-Golgi apparatus. Procathepsin 
L, as is the case lbr secretory proteins in general, may be 
secreted via secretion granules. 
To clarify the processing mechanism of bone procathepsin 
L after secretion, we partially purified the proteinase under cold 
conditions from long bones of rats receiving low calcium diets 
for one week to enhance the induction of the proteinase. We 
also examined the level of the precursor form of cathepsin L. 
Fig. 2a shows the chromatographic profile on a S-Sepharose 
column. The Z-Phe-Arg-MCA hydrolytic activity of the S- 
Sepharose fraction was resolved into two peaks, 'a' and 'b' at 
about 0.3 and 0.45 M NaC1, respectively. Fractions 68 to 72 
(total 15 ml) were combined, and immediately subjected to 
Western blotting analysis using rabbit anti-rat cathepsin L. As 
shown in lane B, a 39 kDa protein as a precursor form of 
cathepsin L was detected. This fraction was then concentrated 
in sodium acetate buffer, pH 5.5, and subjected to Western 
blotting analysis again. As shown in lane C, the mature nzyme, 
but not the proform, was now detected. The Km of this pro- 
teinase for Z-Phe-Arg-MCA, like rat liver cathepsin L, was 4.5 
/IM. These findings indicate that the rat bone procathepsin L 
was efficiently converted to mature cathepsin L in the acidic 
buffer, mediated by cysteine proteinase(s). The cathepsin L
81 
activity of fraction 'b' was due to a mature cathepsin L, because 
27 kDa mature cathepsin L (heavy chain) was detected in this 
fraction by Western blotting analysis as shown in lane D. 
Smith and Gottesman reported [17] that purified recombi- 
nant human cathepsin L expressed in E. coli was autocatalyti- 
cally converted to the mature enzyme within 5 min below pH 
5.0. Mason and Massey showed [18] that procathepsin L was 
auto-activated by contact with negatively charged materials 
such as dextran sulfate in acidic condition at pH 5.5. Ishidoh and 
Kominami also reported [19] that procathepsin L purified from 
v-Ha-ras transformed NIH3T3 cell conditioned medium was 
autocatalytically converted to the mature nzyme by incubation 
for 30 min at 37°C in sodium acetate buffer, pH 5.5, containing 
dextran sulfate and dithiothreitol. These results support the 
conclusion that rat bone procathepsin L is autoprocessed under 
acidic conditions. To confirm whether cysteine proteinases par- 
ticipate in the processing of bone procathepsin L, procathepsin 
L was partially purified in the presence or absence of 10 5 M 
E-64, incubated in acidic conditions at pH 4.5, and analysed by 
Western blotting. As shown in Fig. 3, E-64 partially inhibited 
the processing of prcathepsin L 37, 33 and 27 kDa (heavy chain) 
multistep processed intermediates being detected (lane A). 
These results suggest that procathepsin L secreted from osteo- 
clasts is converted catalytically, perhaps autocatalytically, to a 
mature form in the acidified lacunae. 
3.3. Conclusion 
Using Western blotting analysis, the level of a 39 kDa precur- 
sor form ofcathepsin L secreted from bone cells into the culture 
media has been found to be markedly enhanced by addition of 
bone resorption stimulators, such as PTH, l~,25-(OH)2D 3 or 
TNF~. The pit formation stimulated by these stimulators for 
the secretion of procathepsin L was inhibited by E-64, while no 
inhibition was observed by CA-074, a specific inhibitor of 
cathepsin B. Cathepsin L secreted as a proform from the acti- 
vated osteoclasts induced by various enhancers may be the 
main proteinase responsible for bone collagen degradation. 
The procathepsin L partially purified from rat long bones was 
rapidly converted to a mature enzyme under acidic conditions 
and this conversion was inhibited by E-64. The protons released 
by osteoclasts participate in the hydrolysis of solid calcium 
hydroxyapatite, and also acidify lacunae to the optimum pH for 
cathepsin L. The procathepsin L secreted from osteoclasts may 
be autocatalytically converted to a mature form to degrade 
bone collagen in the acidified lacunae. 
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